PUBLISHER: Allied Market Research | PRODUCT CODE: 1239495
PUBLISHER: Allied Market Research | PRODUCT CODE: 1239495
The global Blood Pressure Cuffs Market Size was valued at $436.2 million in 2021, and is projected to reach $847.6 million by 2031, growing at a CAGR of 6.8% from 2022 to 2031. Blood pressure readings are taken using a blood pressure cuff (BP Cuff). An inflating rubber bladder that is wrapped around the arm is part of the cuff. The pressure inside the cuff is shown by a pressure meter. The blood pressure cuff is inflated with a tiny, portable air pump. An air valve is used to gradually release air pressure after the cuff has been inflated. While mercury and aneroid cuffs must be used manually with a stethoscope, digital cuffs are automated. When compared to surgical hospitals, stand-alone clinics have a higher percentage of walk-in patients, hence doctors and clinicians most frequently use blood pressure cuffs in order to diagnose and monitor hypertension.
The key factor that drives the growth of the blood pressure cuff market is the rise in the prevalence of hypertension due to changing lifestyles. Moreover, the rising demand for disposable blood pressure cuff and the increasing incidence of cross contaminations in healthcare facilities are the major factors driving the growth of the market. For instance, according to the report published by the World Health Organization, it has been estimated that 1.28 billion adults aged 30-79 years worldwide have hypertension, most (two-thirds) living in low- and middle-income countries, an estimated 46% of adults with hypertension are unaware that they have the condition. Less than half of adults (42%) with hypertension are diagnosed and treated and approximately 1 in 5 adults (21%) with hypertension have it under control. Hypertension is a major cause of premature death worldwide. Thus, the rapidly growing geriatric population and the rise in the prevalence of chronic diseases boost the growth of the market.
However, the high chances of error in digital blood pressure cuff hampers the market growth. Conversely, increased investments in R&D for the development of blood pressure cuff as well as increase in the prevalence of hypertension and chronic heart disease may open new opportunities for the key players to invest in blood pressure cuff which is expected to provide lucrative opportunity for the growth of the market during the forecast period.*
The blood pressure cuff market is segmented on the basis of type, age group, end-user, and region. By type, the market is segmented into the reusable cuffs, disposable cuffs, D-ring cuffs, and others. By age group, it is bifurcated into adult and pediatric. By end user, it is segmented into, hospitals, clinics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the blood pressure cuff market share in 2021 and is anticipated to remain dominant during the forecast period. The blood pressure cuff market is mainly driven by the presence of well-established healthcare facilities for medical devices, a growing geriatric population, an increasing prevalence of hypertension, and growing demand for blood monitoring devices. Furthermore, increasing investment by pharmaceutical companies in R&D activities to design technologically advanced medical devices through innovative research is expected to fuel market growth.
Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of a rapidly growing geriatric population, rising incidence of hypertension and chronic disorders, and improvement in the healthcare infrastructure are set to drive the market in the Asia-Pacific region.
The key players that operate in the blood pressure cuff market are: American Diagnostic Corporation, Baxter, Cardinal Health, Elanor Surgical, General Electric Company, Koninklijke Philips N.V, Medline Industries LP, Omron Healthcare Inc, Spacelabs Healthcare, and SPENGLER HOLTEX Group.